Sort
30,917 grants matching “tumor microenvironment”
Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis
$556,850Tien Peng · University Of California, San Francisco · R01 · FY2023 · HL
Targeting B7-H3 in ovarian cancer
$556,817Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$556,764Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Biology of AR+ prostate cancer metastases and the role of the microenvironment
$556,681Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
$556,615Manuel L Penichet · University Of California Los Angeles · R01 · FY2016 · CA
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer
$556,615Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2020 · CA
Protein Kinase Signaling in the Genotoxic Stress Response
$556,545Michael B Yaffe · Massachusetts Institute Of Technology · R35 · FY2018 · ES
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma
$556,541Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2025 · NS
Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$556,513Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
Targeting MTOR signaling in pancreatic cancer
$556,470Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,372Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2021 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,372Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2022 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,357Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2020 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,354Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2019 · CA
Systems Modeling of Tumor Heterogeneity and Therapy Response in Colorectal Cancer
$556,323Fiona Ginty · General Electric Global Research Ctr · R01 · FY2020 · CA
PET-EPRI
$556,193Raymond Robert Raylman · West Virginia University · R01 · FY2021 · EB
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$556,171James S Duncan · Yale University · R01 · FY2024 · CA
Ex vivo analysis of human brain tumor cells in a microvascular niche model
$556,102Rong Fan · Yale University · R01 · FY2020 · CA
Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption
$556,033Katja A Lamia · Scripps Research Institute, The · R01 · FY2024 · CA
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$555,865David Reardon · Brigham And Women'S Hospital · P01 · FY2022 · CA
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$555,851William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$555,814Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies
$555,770Wei Zhang · Wake Forest University Health Sciences · R01 · FY2023 · CA
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies
$555,768Wei Zhang · Wake Forest University Health Sciences · R01 · FY2025 · CA
Lactate production by tumor associated macrophages promotes tumorigenesis
$555,737Lev Becker · University Of Chicago · R01 · FY2022 · CA